Search
Now showing items 1-2 of 2
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Dove Medical Press, 2022-11)
Purpose
Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...
Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders
(OAE Publishing, 2021-07)
Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...